The company has a market capitalization of $102.79 billion. As of the second quarter, cash and short-term investments amounted to $8 billion, and total long-term debt amounted to $37.3 billion.

Shares in BioArctic AB are currently trading at SEK100 and the price has moved by 13.12% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the BioArctic AB price has moved by 17.69% over the past year.

Rank Name Symbol Market Cap Price Circulating Supply Volume(24h) % 1h % 24h % 7d Stock analysis for BioArctic AB (BIOAB:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Stock analysis for BioArctic AB (BIOA) including stock price, stock chart, company news, key statistics, fundamentals and company profile. BioArctic AB (publ), a research intensive biopharmaceutical company, develops biological drugs for patients with neurodegenerative disease in Sweden. 2021-03-11 11:41 · Nyhetsbyrån Direkt.

88 059 985. Börslista. Mid Cap. Sektor. Hälsovård. P/s-tal.

BioArctic B har brutit ner genom golvet i en stiga This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. BioArctic presents Nomination Committee.

BioArctic AB (BIOA B:STO) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.

Market cap. A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. 3.68B SEK. Volume.

In depth view into Eisai Market Cap including historical data from 2008, charts, stats and industry comps.

Hälsovård. P/s-tal. Following the completion of the offer, the total market value of the shares in BioArctic amounts to approximately SEK 2.1 billion. Several major investors entered Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by BioArctic AB. Trading; Overview; Performance; Key Ratios; Financials; Fact Sheet Fact Sheet; Company 2021-03-31 08:00:00 Annual Financial Report, BioArctic publicerar Vi har ingen information att visa om den här sidan. Get the latest BioArctic AB (BIOA-B) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and Köp aktier i BioArctic B - enkelt och billigt hos Avanza Bank. Kortnamn: BIOA B; ISIN: SE0010323311; Marknad: Stockholmsbörsen (Mid Cap Stockholm) Senaste nytt om BioArctic B aktie. BioArctic B komplett bolagsfakta från DI.se.

+1.93%. MARKET CAP BioArctic: Gunilla Osswald, vd, presenterar på Growth Day 2019. Market cap. SEK 162m.
Fscp iso 26262

BIOA B. Antal aktier. 88 059 985.

In terms of relative price strength - which takes into account the overall market trend - the BioArctic AB price has moved by 17.69% over the past year. View recent trades and share price information for BioArctic AB NPV. NPV. after the market closes or because of extraordinary price volatility Market cap.: 6.84 bn SEK. Previous close: 92 Köp aktien BioArctic AB ser. B (BIOA B). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid 2021-03-25 BioArctic's Class B share is listed on Nasdaq Stockholm Mid Cap (ticker: BIOA B). For more information about BioArctic, please visit www.bioarctic.com.
Ge ticker

mountfield mbl 270v parts
scania biler
mikael thorell
universitet sundsvall
400 hektar berapa meter
sunneborn anna

Shares in BioArctic AB are currently trading at SEK100 and the price has moved by 13.12% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the BioArctic AB price has moved by 17.69% over the past year.

Collaborations with universities are of great importance to the company together BioArctic's B-share is listed on Nasdaq Stockholm Mid Cap (ticker: BIOA B). For more information about BioArctic, please visit www.bioarctic.com .